I-GSK-2018682

Igama Lekhemikhali:

4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid

Ikhodi ye-SMILES:

O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3

Ikhodi ye-InChi:

I-InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6- 18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H ,28,29)

I-InChi Key:

I-FIGDBFIDKDNIG-UHFFFAOYSA-N

Igama elingukhiye:

1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682;GSK2018682; 2018682

Ukunyibilika:I-Soluble ku-DMSO

Isitoreji:0 - 4 C isikhathi esifushane (izinsuku ukuya emavikini), noma -20 C isikhathi eside (izinyanga).

Incazelo:

I-GSK2018682 iyi-agonist ye-S1P1 kanye ne-S1P5 receptors.

Okuqondiwe: Ama-Agonists kwabamukeli be-S1P1 kanye ne-S1P5